(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid(CAS: 85441-61-8)

This compound falls under the Classification, Labelling, and Packaging (CLP) regulation for hazardous substances, the REACH regulation for registration, evaluation, authorization, and restriction of chemicals, and is subject to FDA and EPA regulations for pharmaceutical and agricultural use. Specific safety data sheets (SDS) and compliance with local environmental laws are essential.

Alternative reagents such as (3R)-2-{N-[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid and similar isoquinoline derivatives can sometimes be used as alternatives. However, these may not be chemically equivalent and should be evaluated carefully for compatibility with the desired synthesis pathway.

Research is focusing on the drug discovery and development of this compound for potential therapeutic applications. Market trends indicate increasing interest in its use as a potential antiviral and anticancer agent. However, further studies are needed to validate its efficacy and safety.

Waste containing this compound should be collected in sealed containers and stored in a cool, dry place. Proper incineration or professional waste disposal services should be used. Ensure that all disposal methods comply with local and national regulations to prevent environmental contamination. Protective gear should be worn during handling to ensure safety.